2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Feasibility and safety

M.R. Landers, J.W. Navalta (Las Vegas, NV, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Signal of efficacy

M.R. Landers, J.W. Navalta (Las Vegas, NV, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)

V.K. Hinson, J. Elm, A. Delambo, T. Turner (Charleston, SC, USA)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A randomized controlled clinical study to evaluate efficacy, safety and tolerability of SC L-dopa/carbidopa (ND0612H) infusion regimens in fluctuating PD patients

K. Kieburtz, C.W. Olanow, Y. Cohen, S. Oren (Rochester, NY, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A survey of impulse control disorders in Chinese patients with Parkinson’s disease and literature review

Q. Xiao, X. Wang, Y. Tan, M. Wei (Shanghai, People's Republic of China)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Abnormal motor sequence representation in dystonia

M.J. Jaynes, J.W. Mink (Rochester, NY, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

AbobotulinumtoxinA for cervical dystonia: A meta-analysis of injection practices across 5 countries

R. Trosch, V.P. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

AbobotulinumtoxinA for cervical dystonia: International treatment patterns

T.M. Chung, C. Colosimo, V.P. Misra, D. Charles, P. Maisonobe, S. Om (São Paulo, Brazil)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Active movement discrimination of the ankle in Parkinson’s disease

H.E. Teasdale, E.A. Preston, G. Waddington (Canberra, Australia)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2